Stay updated on Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, replacing the previous entry. This signals a new version of the page is published, typically reflecting minor edits or metadata updates rather than substantive changes to study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRemoved the related resources labels/links for Lung cancer, related topics:, and MedlinePlus Genetics from the page, reducing external topic navigation in the related resources section.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded a Publications entry with a PubMed-cited article on the BTCRC-LUN17-127 Phase I/II trial of plinabulin with nivolumab and ipilimumab in recurrent SCLC; updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.4%

- Check54 days agoChange DetectedLung cancer and related topics: MedlinePlus Genetics were removed from the page's topic navigation. The core study information remains unchanged.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Lung cancer and related topics (MedlinePlus Genetics); updated page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.